Union Minister of Commerce and Industry Piyush Goyal has said that the theme of BioAsia 2025, 'Catalyst of Change' captures India's growing leadership in...
India should transform from being production-centric to an innovation-dependent player on the world stage...
Telangana received investment commitments from the life sciences sector of ?11,100 crore, which is meant to...
India's CRDMO sector has good potential for growth, with the estimated size of the market projected to...
In a meeting of state drug regulators held on Monday under the Nasha Mukt Bharat Abhiyan, Union Health Secretary Punya Salila Srivastav stressed the...
India is prepared to take over as a substitute location for early-stage clinical studies in order to lessen the effects of interruptions like the conflict between Russia and Ukraine, an executive at contract research firm Parexel said.
BioAsia 2025 has set the stage for Hyderabad to solidify its position as a global life sciences hub. With 11 pharmaceutical companies pledging investments worth Rs 5,445 crore and creating 9,800 jobs, the sector is witnessing strong momentum. The tot
Mankind Pharma, known for its Manforce condoms and Prega News pregnancy tests, has presented a formulation for...
The Indian pharmaceutical industry remains robust in spite of potential trade challenges as U.S. President Donald Trump considers imposing tariffs on medication imports. Industry specialists are assured that Indian pharmaceutical firms will retain th
According to Marksans Pharma, its subsidiary company, Relonchem, has received marketing authorization for...
, CDSCO.jpg)
